BSE Live
Prev. Close
Open Price
Bid Price (Qty.)
()
Offer Price (Qty.)
()
NSE Live
Mar 09, 15:55Prev. Close
19.61
Open Price
19.00
Bid Price (Qty.)
18.68 (1)
Offer Price (Qty.)
0.00 (0)
| Cash Flow of Balaxi Pharmaceuticals (in Rs. Cr.) | Mar 15 | Mar 14 | Mar 13 | Mar 12 | |
| 12 mths | 12 mths | 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | 0.15 | 0.15 | 0.06 | 0.14 | |
| Net CashFlow From Operating Activities | 0.21 | -0.24 | 0.32 | -0.01 | |
| Net Cash Used In Investing Activities | -3.11 | 0.33 | -0.05 | 0.34 | |
| Net Cash Used From Financing Activities | 2.38 | -0.07 | -0.29 | 0.21 | |
| Foreign Exchange Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | -0.52 | 0.02 | -0.01 | 0.54 | |
| Cash And Cash Equivalents Begin of Year | 0.55 | 0.53 | 0.55 | 0.02 | |
| Cash And Cash Equivalents End Of Year | 0.02 | 0.55 | 0.54 | 0.55 |
29.01.2026
Balaxi Pharma Consolidated December 2025 Net Sales at Rs 72.54 crore, down 1.02% Y-o-Y
29.01.2026
Balaxi Pharma Standalone December 2025 Net Sales at Rs 24.59 crore, up 120.41% Y-o-Y
19.11.2025
Balaxi Pharma Consolidated September 2025 Net Sales at Rs 56.18 crore, down 27.41% Y-o-Y
18.11.2025
Balaxi Pharma Standalone September 2025 Net Sales at Rs 19.31 crore, down 8.72% Y-o-Y
29.01.2026
Balaxi Pharma Consolidated December 2025 Net Sales at Rs 72.54 crore, down 1.02% Y-o-Y
29.01.2026
Balaxi Pharma Standalone December 2025 Net Sales at Rs 24.59 crore, up 120.41% Y-o-Y
19.11.2025
Balaxi Pharma Consolidated September 2025 Net Sales at Rs 56.18 crore, down 27.41% Y-o-Y
18.11.2025
Balaxi Pharma Standalone September 2025 Net Sales at Rs 19.31 crore, down 8.72% Y-o-Y
15.06.2017
24.04.2017
18.04.2017
18.04.2017
14.02.2017
13.02.2017
12.02.2017
09.12.2016